Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

被引:35
|
作者
Moon, Joon Ho [1 ]
Koo, Bo Kyung [1 ,2 ]
Kim, Won [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[3] Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Non-alcoholic fatty liver disease; Sarcopenia; Mortality; Nationwide survey; FIBROSIS STAGE; ASSOCIATION; DIAGNOSIS; RISK; MANAGEMENT; AGE; INFLAMMATION; FEATURES; OUTCOMES;
D O I
10.1002/jcsm.12719
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Sarcopenia is an independent risk factor not only for advanced-stage non-alcoholic fatty liver disease (NAFLD) but also for mortality. We investigated the association of sarcopenia and/or NAFLD with mortality among the Korean general population. Methods Individuals aged 35-75 years without any history of cancer, ischaemic heart disease, ischaemic stroke, or secondary causes of chronic liver disease were selected from the Korean National Health and Nutrition Examination Surveys from 2008 to 2015. Their mortality data until December 2018 were retrieved from the National Death Registry. NAFLD and sarcopenia were defined by hepatic steatosis index and appendicular skeletal muscle mass divided by body mass index (BMI), respectively. Results A total of 28 060 subjects were analysed [mean age, 50.6 (standard error, 0.1) years, 48.2 (0.3) % men]; the median follow-up duration was of 6.8 (interquartile range, 4.8, 8.4) years. NAFLD predicted mortality after adjustment for age, sex, BMI, hypertension, dyslipidaemia, and smoking (HR 1.32, 95% CI 1.03-1.70), but this prediction lost its statistical significance after additional adjustment for diabetes mellitus. In contrast, NAFLD with advanced fibrosis independently increased the risk of mortality after adjustment for all covariates (HR 1.68, 95% CI 1.02-2.79). Stratified analysis revealed that NAFLD and sarcopenia additively increased the risk of mortality as an ordinal scale (HR 1.46, 95% CI 1.18-1.81, P for trend = 0.001). The coexistence of NAFLD and sarcopenia increased the risk of mortality by almost twice as much, even after adjustment for advanced fibrosis (HR 2.18, 95% CI 1.38-3.44). Conclusions Concurrent NAFLD and sarcopenia conferred a two-fold higher risk of mortality. The observation that NAFLD and sarcopenia additively increase mortality suggests that risk stratification would be helpful in predicting mortality among those with metabolic derangement.
引用
收藏
页码:964 / 972
页数:9
相关论文
共 50 条
  • [11] Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
    Lim, Yohwan
    Jeong, Seogsong
    Hong, Myunghee
    Han, Hyun Wook
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (06)
  • [12] Cigarette Smoking Increased Risk of Overall Mortality in Patients With Non-alcoholic Fatty Liver Disease: A Nationwide Population-Based Cohort Study
    Charatcharoenwitthaya, Phunchai
    Karaketklang, Khemajira
    Aekplakorn, Wichai
    FRONTIERS IN MEDICINE, 2020, 7
  • [13] Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults
    Lee, Sung-Bum
    Kwon, Yu-Jin
    Jung, Dong-Hyuk
    Kim, Jong-Koo
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [14] Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
    Almeida, Naiade Silveira
    Rocha, Raquel
    de Souza, Claudineia Almeida
    da Cruz, Ana Carolina Sirelli
    Ribeiro, Bruna dos Reis
    Vieira, Luiza Valois
    Daltro, Carla
    Silva, Rafael
    Sarno, Manoel
    Cotrim, Helma Pinchemel
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (08) : 1643 - 1651
  • [15] Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
    Lee, Jun-Hyuk
    Lee, Hye-Sun
    Lee, Byoung-Kwon
    Kwon, Yu-Jin
    Lee, Ji-Won
    BIOLOGY-BASEL, 2021, 10 (02): : 1 - 14
  • [16] Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort
    Yoo, Hae Won
    Jin, Hyun Young
    Yon, Dong Keon
    Effenberger, Maria
    Shin, Youn Ho
    Kim, So Young
    Yang, Jee Myung
    Kim, Min Seo
    Koyanagi, Ai
    Jacob, Louis
    Smith, Lee
    Yoo, In Kyung
    Shin, Jae Il
    Lee, Seung Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (41)
  • [17] Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults
    Lee, Inhwan
    Kim, Jeonghyeon
    Kang, Hyunsik
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (11)
  • [18] Diet in Non-Alcoholic Fatty Liver Disease
    Miller, Jennifer B.
    Henry, Zachary
    PRACTICAL GASTROENTEROLOGY, 2019, 43 (10) : 24 - +
  • [19] Non-Alcoholic Fatty Liver Disease in Cuba
    Castellanos-Fernandez, Marlen, I
    Crespo-Ramirez, Eduardo
    del Valle-Diaz, Sergio
    Barreto-Suarez, Eduardo
    Diaz-Elias, Javier O.
    Santalo-Rodriguez, Lorenzo
    Corrales-Alonso, Sahili
    Morales-Martinez, Ignacio
    Cedeno-Ramirez, Elisa
    Perez-Gonzalez, Teresita
    Gonzalez-Suero, Sila M.
    Ruenes-Domech, Caridad
    Infante-Velazquez, Mirtha
    Borges-Gonzalez, Susana A.
    Elvirez-Gutierrez, Angela
    Lazo-del Vallin, Sacha
    Villa-Jimenez, Oscar M.
    Labrada-Moreno, Liana M.
    MEDICC REVIEW, 2021, 23 (01) : 64 - 71
  • [20] Non-alcoholic fatty liver disease in pregnancy
    Benson, Charlotte S.
    Cobbold, Jeremy F.
    Frise, Charlotte J.
    OBSTETRIC MEDICINE, 2023, 16 (02) : 116 - 119